BioAv Cancer Research Results
BioAv, bioavailability: Click to Expand ⟱
| Source: |
| Type: measurement |
Bioavailability (usually in %) absorbed by the body.
|
Scientific Papers found: Click to Expand⟱
*Inflam↓, AntiCan↑, BioAv↝, BioAv⇅, BioAv↓, CYP3A2↓, P-gp↓,
*BBB↑, *other↑, *P-gp↓, *toxicity⇅, *BioAv⇅, *Dose↑, *ABC↓, *MRP1↓, *5HT↑, *GABA↑, *eff↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
antiOx↑, *Bacteria↓, AntiCan↑, *Inflam↓, *cardioP↑, *AntiDiabetic↑, *GutMicro↑, *eff↑, *eff↑, *ROS↓, *IronCh↑, *neuroP↑, *AChE↓, *BChE↓, *chemoPv↑, *BioAv⇅,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
*lipid-P↓, *ROS↓, *Inflam↓, *BP↓, *cardioP↑, *chemoPv↑, *BioAv⇅, *antiOx↑, *Risk↓, *5LO↓, *AntiAg↑, *Imm↑, *NF-kB↓, *other↓, CYP1A1↓, COX2↓, *Obesity↓, *cognitive↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
*AntiCan↑, *AntiDiabetic↑, *cardioP↑, *toxicity↝, *GutMicro↑, *neuroP↑, *BioAv⇅, *BioAv↝, *antiOx↑, *Inflam↑, *AntiArt↑, *TNF-α↓, *IL6↓, *IL10↓, *GSH↑, *GPx↑, *Catalase↑, *MDA↓, *TAC↑, TumCMig↓, TumCI↓, Akt↑, FOXO3↑, Casp3↑, Casp9↑, P21↑, angioG↓, TumCI↓, Apoptosis↑, NF-kB↓, eff↑, eff↑, ChemoSen↑, NA↑, Casp3↑, Casp9↑, *AntiDiabetic↑, *glucose↓, *ROS↓, *Inflam↓, *MDA↓, *GSH↑, *BioAv↑,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned ⓘ
NA↑, 1,
Redox & Oxidative Stress ⓘ
antiOx↑, 1, CYP1A1↓, 1,
Core Metabolism/Glycolysis ⓘ
CYP3A2↓, 1,
Cell Death ⓘ
Akt↑, 1, Apoptosis↑, 1, Casp3↑, 2, Casp9↑, 2,
Cell Cycle & Senescence ⓘ
P21↑, 1,
Proliferation, Differentiation & Cell State ⓘ
FOXO3↑, 1,
Migration ⓘ
TumCI↓, 2, TumCMig↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1,
Barriers & Transport ⓘ
P-gp↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, NF-kB↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv⇅, 1, BioAv↝, 1, ChemoSen↑, 1, eff↑, 2,
Functional Outcomes ⓘ
AntiCan↑, 2,
Total Targets: 22
Pathway results for Effect on Normal Cells:
NA, unassigned ⓘ
AntiArt↑, 1,
Redox & Oxidative Stress ⓘ
antiOx↑, 2, Catalase↑, 1, GPx↑, 1, GSH↑, 2, lipid-P↓, 1, MDA↓, 2, ROS↓, 3, TAC↑, 1,
Metal & Cofactor Biology ⓘ
IronCh↑, 1,
Core Metabolism/Glycolysis ⓘ
glucose↓, 1,
Transcription & Epigenetics ⓘ
other↓, 1, other↑, 1,
Migration ⓘ
5LO↓, 1, AntiAg↑, 1,
Barriers & Transport ⓘ
BBB↑, 1, P-gp↓, 1,
Immune & Inflammatory Signaling ⓘ
IL10↓, 1, IL6↓, 1, Imm↑, 1, Inflam↓, 4, Inflam↑, 1, NF-kB↓, 1, TNF-α↓, 1,
Synaptic & Neurotransmission ⓘ
5HT↑, 1, AChE↓, 1, BChE↓, 1, GABA↑, 1,
Drug Metabolism & Resistance ⓘ
ABC↓, 1, BioAv↑, 1, BioAv⇅, 4, BioAv↝, 1, Dose↑, 1, eff↑, 3, MRP1↓, 1,
Clinical Biomarkers ⓘ
BP↓, 1, GutMicro↑, 2, IL6↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, AntiDiabetic↑, 3, cardioP↑, 3, chemoPv↑, 2, cognitive↑, 1, neuroP↑, 2, Obesity↓, 1, Risk↓, 1, toxicity⇅, 1, toxicity↝, 1,
Infection & Microbiome ⓘ
Bacteria↓, 1,
Total Targets: 49
Scientific Paper Hit Count for: BioAv, bioavailability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:792 State#:% Dir#:3
wNotes=0 sortOrder:rid,rpid
Home Page